These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

589 related articles for article (PubMed ID: 12746701)

  • 21. Treatment of spasticity with botulinum toxin: a double-blind study.
    Snow BJ; Tsui JK; Bhatt MH; Varelas M; Hashimoto SA; Calne DB
    Ann Neurol; 1990 Oct; 28(4):512-5. PubMed ID: 2252363
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Botulinum A toxin for treatment of lower limb spasticity in cerebral palsy: gait analysis in 49 patients.
    Papadonikolakis AS; Vekris MD; Korompilias AV; Kostas JP; Ristanis SE; Soucacos PN
    Acta Orthop Scand; 2003 Dec; 74(6):749-55. PubMed ID: 14763710
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A randomized controlled trial to compare two botulinum toxin injection techniques on the functional improvement of the leg of children with cerebral palsy.
    Kaishou Xu ; Tiebin Yan ; Jianning Mai
    Clin Rehabil; 2009 Sep; 23(9):800-11. PubMed ID: 19482892
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Functional and clinical changes in upper limb spastic patients treated with botulinum toxin (BTX).
    Panizza M; Castagna M; di Summa A; Saibene L; Grioni G; Nilsson J
    Funct Neurol; 2000; 15(3):147-55. PubMed ID: 11062843
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Botulinum toxin type A in the treatment plan for cerebral palsy].
    Strobl W
    Wien Klin Wochenschr; 2001; 113 Suppl 4():30-5. PubMed ID: 15506050
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Botulinum toxin in the treatment of spasticity].
    Arriola-Arellano E; Chacón J; Alvarez-López M; Balbuena-García M; Fuentes-Pradera J; Vicente-Baz D
    Rev Neurol; 2006 Feb 16-28; 42(4):250-1. PubMed ID: 16521066
    [No Abstract]   [Full Text] [Related]  

  • 27. Treatment of spasticity with botulinum toxin.
    O'Brien CF
    Clin J Pain; 2002; 18(6 Suppl):S182-90. PubMed ID: 12569967
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Use of botulinum toxin type A and type B for spasticity in upper and lower limbs.
    Bell KR; Williams F
    Phys Med Rehabil Clin N Am; 2003 Nov; 14(4):821-35. PubMed ID: 14580040
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Management of spasticity in adults: practical application of botulinum toxin.
    Pathak MS; Nguyen HT; Graham HK; Moore AP
    Eur J Neurol; 2006 Feb; 13 Suppl 1():42-50. PubMed ID: 16417597
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Botulinum toxin type B in the spastic arm: a randomized, double-blind, placebo-controlled, preliminary study.
    Gracies JM; Bayle N; Goldberg S; Simpson DM
    Arch Phys Med Rehabil; 2014 Jul; 95(7):1303-11. PubMed ID: 24709034
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Botulinum toxin in movement disorders.
    Papapetropoulos S; Singer C
    Semin Neurol; 2007 Apr; 27(2):183-94. PubMed ID: 17390263
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Treatment of spasticity with botulinum toxin].
    Mémin B; Pollak P; Hommel M; Perret J
    Rev Neurol (Paris); 1992; 148(3):212-4. PubMed ID: 1604136
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Botulinum toxin for treatment of spasticity in adults.
    Reichel G
    J Neurol; 2001 Apr; 248 Suppl 1():25-7. PubMed ID: 11357235
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Treatment with botulinum toxin in neurologic pediatrics].
    Justus N; Lee SH; Berweck S; Heinen F
    Kinderkrankenschwester; 2007 Jul; 26(7):274-6. PubMed ID: 17726921
    [No Abstract]   [Full Text] [Related]  

  • 35. Botulinum toxin--mechanisms of action and clinical use in spasticity.
    Barnes M
    J Rehabil Med; 2003 May; (41 Suppl):56-9. PubMed ID: 12817658
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of botulinum toxin A on upper limb spasticity in children with cerebral palsy.
    Friedman A; Diamond M; Johnston MV; Daffner C
    Am J Phys Med Rehabil; 2000; 79(1):53-9; quiz 75-6. PubMed ID: 10678604
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Botulinum toxin Type A. Indications and results].
    Póo P; López-Casas JA; Galván-Manso M; Aquino-Fariña L; Terricabras-Carol L; Campistol J
    Rev Neurol; 2003 Jul 1-15; 37(1):74-80. PubMed ID: 12861515
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Guidelines for the treatment of child spasticity using botulinum toxin].
    Pascual-Pascual SI; Herrera-Galante A; Póo P; García-Aymerich V; Aguilar-Barberà M; Bori-Fortuny I; García-Ruiz PJ; Garreta-Figuera R; Lanzas-Melendo G; de Miguel-León I; Miquel-Rodríguez F; Vivancos-Matellano F;
    Rev Neurol; 2007 Mar 1-15; 44(5):303-9. PubMed ID: 17342682
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Spasticity. Physical therapy, preventive measures and treatment].
    Gay S; Egon G
    Ann Fr Anesth Reanim; 2005 Jun; 24(6):663-6. PubMed ID: 15950113
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Botulin toxin for spasticity in spinal cord damage by treating the motor endplate].
    Keren O; Shinberg F; Catz A; Giladi N
    Harefuah; 2000 Feb; 138(3):204-8, 270. PubMed ID: 10883093
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 30.